In Treatment of Hair loss Kera XL M Solution is a medicine used to treat common hereditary hair loss. It can prevent further hair loss and help hair to re-grow. It works by increasing blood flow to the hair follicles on your scalp, which prevents hair cell death and also enhances new hair growth. It is most effective for baldness or thinning at the top of the scalp but less effective at the front or for receding hairline. Benefits are less likely if you have been bald for many years or have a large area of hair loss. Kera XL M Solution is not suitable for sudden or unexplained hair loss. It is considered a safe medicine. There are separate products for men and women and you should follow your doctor’s instructions carefully while using Kera XL M Solution. Regrowth of hair improves your appearance, boosts your confidence, and enhances your social life. Use it regularly to maintain hair growth and to get the maximum benefits. Consult your doctor if you notice any changes in the hair growth while using Kera XL M Solution.
No interaction found/established
Kera XL M Solution may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Kera XL M Solution is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
No interaction found/established
No interaction found/established
No interaction found/established
If you miss a dose of Kera XL M Solution, apply it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Alkem Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: La Med India || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Era Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Dr. Johns Laboratories Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Fulford India Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Dabur India Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Pretium Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zhenpi Life Sciences Pvt Ltd || ₹14.5/tablet (25% cheaper)